During the past decade, Neurology & Neuroscience Associates, Inc. conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 9 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 7 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Neurology & Neuroscience Associates, Inc." #1 sponsor was "Celgene" with 4 trials, followed by "Novartis" with 3 trials sponsored, "Genentech, Inc." with 2 trials sponsored, "Opexa Therapeutics, Inc." with 2 trials sponsored and "Otsuka Pharmaceutical Development & Commercialization, Inc." with 2 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Neurology & Neuroscience Associates, Inc." #1 collaborator was "Sunovion" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Neurology & Neuroscience Associates, Inc." are "Multiple Sclerosis" (7 trials), "Agitation in Patients With Dementia of the Alzheimer's Type" (2 trials), "Multiple Sclerosis, Relapsing-Remitting" (2 trials), "Relapsing Multiple Sclerosis" (2 trials) and "Chronic Ischemic Stroke" (1 trials). Many other conditions were trialed in "Neurology & Neuroscience Associates, Inc." in a lesser frequency.

Most popular intervention types in "Neurology & Neuroscience Associates, Inc." are "Drug" (16 trials), "Biological" (3 trials), "Device" (2 trials), "Other" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Ozanimod" (3 trials), "AVP-786" (2 trials), "Interferon beta-1a" (2 trials) and "Ocrelizumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Neurology & Neuroscience Associates, Inc." are 21 trials for "All" genders.

Currently, there are NaN active trials in "Neurology & Neuroscience Associates, Inc.". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 15 completed trials in Neurology & Neuroscience Associates, Inc., 1 suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Neurology & Neuroscience Associates, Inc., 1 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".